US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 13, 2023 (4 years ago)

Diltiazem Hydrochloride Extended-Release Capsules, USP, 360 mg; Rx only; 90-count…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.

What was recalled

Diltiazem Hydrochloride Extended-Release Capsules, USP, 360 mg; Rx only; 90-count bottles, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 47335-679-81

Recalling firm
Sun Pharmaceutical Industries INC
NDC code
47335-679-81
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0262-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all